buchspektrum Internet-Buchhandlung

Neuerscheinungen 2017

Stand: 2020-02-01
Schnellsuche
ISBN/Stichwort/Autor
Herderstraße 10
10625 Berlin
Tel.: 030 315 714 16
Fax 030 315 714 14
info@buchspektrum.de

Robert C. Groves, Joanna E. Kusmirek, Mark S. Parker, Leila Rezai Gharai, Samira Shojaee (Beteiligte)

Lung Cancer Screening


Mitarbeit: Parker, Mark S.; Groves, Robert C.; Kusmirek, Joanna E.; Rezai Gharai, Leila; Shojaee, Samira
2017. 120 S. 70 Abb. 152 x 229 mm
Verlag/Jahr: THIEME, STUTTGART 2017
ISBN: 1-62623-513-9 (1626235139)
Neue ISBN: 978-1-62623-513-7 (9781626235137)

Preis und Lieferzeit: Bitte klicken


Lung cancer is the leading cause of cancer-related death among men and women in the U.S. and worldwide. For many decades, lung cancer was the sole cancer among the deadly four without an evidence-based screening method for decreasing mortality. This changed in November 2011, when findings from the National Lung Cancer Screening Trial showed low-dose lung CT screening was more efficacious in reducing deaths in high-risk individuals than conventional radiography. As such, an ever-increasing number of health organizations now recommend this screening protocol.

Lung Cancer Screening by Mark Parker and esteemed VCU Health colleagues, fulfills the dire need for a comprehensive guide explaining the crucial aspects of lung cancer screenings. The first two chapters lay a foundation with discussion of lung cancer epidemiology and risk factors beyond cigarette smoking. Subsequent chapters cover the fundamentals, with clinical pearls on setting up a successful lung cancer screening program, patient eligibility criteria, imaging variances of tumors in the lungs, screening pros and cons, and interpreting/reporting screening results.

The evolution and future of lung cancer screenings

Detection and management of unexpected incidental pulmonary and non-pulmonary findings

Discussion of test cases utilizing the Lung-RADSTM risk-stratifying system for low-dose chest CT screenings

Benefits and potential harms associated with mass lung cancer screening programs including false positive, false negative, and over-diagnosis rates

This state-of-the-art guide is essential reading for radiologists, oncologists, pulmonologists, and internists. It is a must-have bookshelf reference for hospital radiology and oncology departments, in particular for those setting up new lung cancer screening programs.